Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2018
Source ID
10.1016/j.nicl.2018.07.016

Entities

People

  • Cary R. Savage
  • Christopher M. Weise
  • Eric M. Reiman
  • Kewei Chen
  • Xiaoying Kuang
  • Yinghua Chen

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company